Page 16 - Note Regarding News Today

TSX-V: OCO) (“ Oroco” or “ Rodriguez”) of Mexico City to acquire 25 shares of Xochipala Gold, S.A. de C.V. (“ Xochipala Gold”) for US$1.5 million.  Xochipala Gold holds 100% of the registered title (85% of the beneficial ownership) to the seven core concessions (the “ Core Concessions”) of the Company’s Santo Tomas Project.  The shares of Xochipala Gold being acquired currently represent 8.5% of the beneficial ownership of the Core Concessions. Background:  Prior to reachin...

PsyBio and Miami University Broaden Partnership Agreement for the Continued Advancement of its Neuropsychiatric Drug Discovery Platform, Expediting its IND Submission to the FDA News provided by Share this article Share this article PsyBio" or the " Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, announces today that it has amended its master sponsored agreement with Miami University based in Oxford, Ohio (the " Amended Agreement") to exte...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. RespireRx Pharmaceuticals Inc. Provides Update on Its Development Programs RespireRX Pharmaceuticals Inc.April 22, 2021 GMT Glen Rock, N.J., April 22, 2021 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQB: RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signal...

PsyBio Therapeutics Appoints Pharmaceutical Veteran Bob Oliver to its Board of Directors Mr. Oliver joins PsyBio bringing over 25 years of executive pharmaceutical experience having held various senior positions at Otsuka, Wyeth and Johnson & Johnson News provided by Share this article Share this article PsyBio" or the " Company"), a biotechnology company pioneering the next generation of targeted psychoactive medications, is pleased to announce the appointment of Mr. Bob Oliver to the Companys...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medigus: Polyrizon Commenced a Pre-Clinical Study Testing Several Formulations of its Bio-Gel ... Medigus LtdApril 12, 2021 GMT OMER, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Polyrizon Ltd. (which Medigus owns 33.24% of its share capital), a private compa...

April 6, 2021 at 4:52 pm Published by NCV Newswire 4Front Announces Fourth Quarter and Fiscal Year 2020 Results and Provides Business Update Q4 Systemwide Pro Forma Revenue increased to $25.0 million, with full year 2020 Systemwide Pro Forma sales of $88.1 million Q4 Adjusted EBITDA increased 59% sequentially to $5.9 million, representing Adjusted EBITDA margin of 24% Reiterated FY2021 guidance for Systemwide Pro Forma Revenue of $170-180 million and Adjusted EBITDA of $40-50 million ...

Share this article Share this article DETROIT, April 1, 2021 /PRNewswire/ -- Gage Growth Corp. ("Gage" or the "Company"), a leading high-quality craft cannabis brand and operator in Michigan, is pleased to provide the following corporate update: Gage Growth Corp. to Commence Trading on the Canadian Securities Exchange Gage Cannabis Co. Gage is pleased to announce that the Companys subordinate voting shares (the "Shares") will commence trading on the Canadian Securities Exchange under the symb...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Medigus: Charging Robotics Ltd. Signed a Non-Binding MOU to Distribute its Wireless EV Robotic ... Medigus LtdMarch 16, 2021 GMT Global Automax, an Israeli vehicle importer, will have exclusive distribution rights in Israel and Greece OMER, Israel, March 16, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technol...

PsyBio Therapeutics Announces Retention of Market Maker March 04, 2021 08:08 ET | Source: PsyBio Therapeutics Corp. PsyBio Therapeutics Corp. TORONTO, March 04, 2021 (GLOBE NEWSWIRE) -- PsyBio Therapeutics Corp. (TSXV:PSYB) (“ PsyBio” or the “ Company”), a leader in the field of psychedelic research and drug development, announces that, subject to the receipt of approval by the TSX Venture Exchange (“ TSXV”), it has retained Generation IACP Inc. (...

This press release may contain statements that are “ Forward-Looking Statements,” which are based upon the current estimates, assumptions and expectations of theMedigus’ management and its knowledge of the relevant market. Medigus has tried, where possible, to identify such information and statements by using words such as “ anticipate,” “believe,” “envision,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “target,” “pote...